Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5386)
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.58
Total Value
$175.10K
Shares Held After
44,089
% of Holdings
12.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
4,166
Price
$27.33
Total Value
$113.86K
Shares Held After
50,437
% of Holdings
7.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
3,541
Price
$27.33
Total Value
$96.78K
Shares Held After
50,437
% of Holdings
6.6%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
6,207
Price
$82.07
Total Value
$509.40K
Shares Held After
32,105
% of Holdings
16.2%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
9,435
Price
$81.56
Total Value
$769.51K
Shares Held After
38,312
% of Holdings
19.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
4,160
Price
$26.36
Total Value
$109.66K
Shares Held After
19,860
% of Holdings
20.9%
QuidelOrtho Corporation (QDEL)
Strobeck Matthew — Director
Shares
10,000
Price
$23.96
Total Value
$239.59K
Shares Held After
27,775
% of Holdings
36.0%
IRADIMED CORP (IRMD)
ALLEN MONTY K — Director
Shares
1,000
Price
$100.26
Total Value
$100.26K
Shares Held After
21,000
% of Holdings
4.5%
QuidelOrtho Corporation (QDEL)
Busky Joseph M. — Chief Financial Officer
Shares
3,370
Price
$23.66
Total Value
$79.74K
Shares Held After
10,290
% of Holdings
32.8%
QuidelOrtho Corporation (QDEL)
Blaser Brian J. — President and CEO
Shares
10,540
Price
$23.59
Total Value
$248.66K
Shares Held After
40,073
% of Holdings
26.3%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
35,000
Price
$0.03
Total Value
$1.14K
Shares Held After
30,210,988
% of Holdings
0.1%
TALPHERA, INC. (TLPH)
ASADORIAN RAFFI — Chief Financial Officer
Shares
45,000
Price
$0.81
Total Value
$36.55K
Shares Held After
91,256
% of Holdings
49.3%
TALPHERA, INC. (TLPH)
Aslam Shakil — Chief Medical Officer
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
83,178
% of Holdings
42.1%
TALPHERA, INC. (TLPH)
Angotti Vincent J. — Director
Shares
105,364
Price
$0.81
Total Value
$85.59K
Shares Held After
586,954
% of Holdings
18.0%
TALPHERA, INC. (TLPH)
Dasu Badri N — Chief Engineering Officer
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
76,230
% of Holdings
45.9%
Cannabis Sativa, Inc. (CBDS)
TOBIAS DAVID — Director
Shares
300,000
Price
$0.02
Total Value
$5.58K
Shares Held After
25,393
% of Holdings
92.2%
Neuronetics, Inc. (STIM)
MACAN WILLIAM ANDREW — EVP, CLO and CS
Shares
14,120
Price
$1.65
Total Value
$23.30K
Shares Held After
673,561
% of Holdings
2.1%
Neuronetics, Inc. (STIM)
Sullivan Keith J — Director
Shares
33,847
Price
$1.65
Total Value
$55.85K
Shares Held After
1,533,165
% of Holdings
2.2%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
10,348
Price
$9.04
Total Value
$93.55K
Shares Held After
332,412
% of Holdings
3.0%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
124,882
Price
$9.04
Total Value
$1.13M
Shares Held After
3,033,078
% of Holdings
4.0%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
11,446
Price
$9.04
Total Value
$103.47K
Shares Held After
366,356
% of Holdings
3.0%
PULSE BIOSCIENCES, INC. (PLSE)
Danahy Kevin Patrick — Chief Commercial Officer
Shares
20,000
Price
$23.37
Total Value
$467.40K
Shares Held After
43,298
% of Holdings
31.6%
Heartflow, Inc. (HTFL)
Rogers Campbell — Chief Medical Officer
Shares
65,153
Price
$24.49
Total Value
$1.60M
Shares Held After
76,034
% of Holdings
46.1%
Biogen Inc. (BIIB)
Murphy Nicole — Head of Pharm Ops and Tech
Shares
3
Price
$195.03
Total Value
$585.11
Shares Held After
19,611
% of Holdings
0.0%
OCULAR THERAPEUTIX, INC (OCUL)
Waheed Nadia — Chief Medical Officer
Shares
7,863
Price
$9.04
Total Value
$71.08K
Shares Held After
318,417
% of Holdings
2.4%
JOINT Corp (JYNT)
JOBSON CHARLES E — 10% Owner
Shares
15,397
Price
$8.50
Total Value
$130.87K
Shares Held After
1,645,294
% of Holdings
0.9%
GLOBUS MEDICAL INC (GMED)
Huller Kelly — EVP, GC, Corporate Secretary
Shares
10,000
Price
$87.67
Total Value
$876.70K
Shares Held After
0
% of Holdings
100.0%
DEXCOM INC (DXCM)
Heller Bridgette P — Director
Shares
1,012
Price
$68.01
Total Value
$68.83K
Shares Held After
26,019
% of Holdings
3.7%
Anzu Special Acquisition Corp I (ANZU)
Lucas Brent T. — Director
Shares
62,500
Price
$0.40
Total Value
$25.00K
Shares Held After
297,090
% of Holdings
21.0%
Anzu Special Acquisition Corp I (ANZU)
BRYNELSEN CHARLES — Director
Shares
1,000,000
Price
$0.40
Total Value
$400.00K
Shares Held After
1,050,000
% of Holdings
95.2%
Anzu Special Acquisition Corp I (ANZU)
Kantor Susan — Director
Shares
96,150
Price
$0.40
Total Value
$38.46K
Shares Held After
174,037
% of Holdings
55.2%
Anzu Special Acquisition Corp I (ANZU)
Potashnick Robert — Interim CFO
Shares
212,500
Price
$0.40
Total Value
$85.00K
Shares Held After
212,500
% of Holdings
100.0%
Anzu Special Acquisition Corp I (ANZU)
Patel Mona Chetan — Director
Shares
312,500
Price
$0.40
Total Value
$125.00K
Shares Held After
332,500
% of Holdings
94.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
90,000
Price
$5.23
Total Value
$470.99K
Shares Held After
214,657
% of Holdings
29.5%
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Yi Sang — Group President, Asia Pacific
Shares
1,000
Price
$96.49
Total Value
$96.49K
Shares Held After
17,670
% of Holdings
5.4%
ANI PHARMACEUTICALS INC (ANIP)
Mutz Christopher — HEAD OF RARE DISEASE
Shares
7,032
Price
$76.55
Total Value
$538.30K
Shares Held After
92,566
% of Holdings
7.1%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
3,500
Price
$50.23
Total Value
$175.79K
Shares Held After
306,788
% of Holdings
1.1%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
30,124
Price
$9.69
Total Value
$291.84K
Shares Held After
231,600
% of Holdings
13.0%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
8,908
Price
$9.18
Total Value
$81.81K
Shares Held After
201,476
% of Holdings
4.4%
Anzu Special Acquisition Corp I (ANZU)
TAYLOR GLEN A — 10% Owner
Shares
18,750,000
Price
$0.40
Total Value
$7.50M
Shares Held After
21,703,607
% of Holdings
86.4%
Entera Bio Ltd. (ENTX)
Rubin Steven D — Director
Shares
5,000
Price
$1.49
Total Value
$7.45K
Shares Held After
15,000
% of Holdings
33.3%
ZIVO Bioscience, Inc. (ZIVO)
STROME MARK E — 10% Owner
Shares
20,000
Price
$9.77
Total Value
$195.40K
Shares Held After
472,942
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,000
Price
$26.72
Total Value
$4.01M
Shares Held After
15,778,113
% of Holdings
0.9%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
275,000
Price
$26.76
Total Value
$7.36M
Shares Held After
15,503,113
% of Holdings
1.7%
Showing 2701–2750 of 5386 transactions (page 55 of 108)